Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Andrew Combs Insider Profile
4 Followers
Andrew Combs, Chief Chemistry Officer at Prelude Therapeutics, holds 377.62K shares in Prelude Therapeutics (Ticker: PRLD).
Andrew Combs Prelude Therapeutics (PRLD)Chief Chemistry Officer
Prelude Therapeutics (PRLD)
Chief Chemistry Officer
Ranked #77,397 out of 100,285 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-26.00%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Chemistry Officer
Roles that Andrew Combs holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 29, 2020 - Sep 29, 2021
Return:+7.10%
The most profitable trade made by Andrew Combs
Andrew Combs's Trading History
List of latest transactions for each holding click on a transaction to see Andrew Combs's performance on stock
You May Also Like
Andrew Combs insider profile FAQ
What is the percentage of profitable transactions made by Andrew Combs?
The percentage of profitable transactions made by Andrew Combs is 33%.
What is the average return per transaction made by Andrew Combs?
The average return per transaction made by Andrew Combs is -26.00%.
What stocks does Andrew Combs hold?
Andrew Combs holds: PRLD stocks.
What was Andrew Combs’s latest transaction?
Andrew Combs latest transaction was an Uninformative Buy of $3.54K.
What was Andrew Combs's most profitable transaction?
Andrew Combs’s most profitable transaction was an Informative Buy of PRLD stock on September 29, 2020. The return on the trade was 7.10%.
What is Andrew Combs's role in Prelude Therapeutics?
Andrew Combs's role in Prelude Therapeutics is Chief Chemistry Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.